Skip to main content
Clinical Trials/ACTRN12612000036819
ACTRN12612000036819
Completed
未知

A randomised-controlled trial of oral arginine supplementation on the healing of foot ulcers in patients with type 2 diabetes

orthern Hospital0 sites8 target enrollmentStarted: January 9, 2012Last updated:

Overview

Phase
未知
Status
Completed
Sponsor
orthern Hospital
Enrollment
8

Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional
Allocation
Randomised controlled trial
Primary Purpose
Treatment
Masking
Open (masking not used)

Eligibility Criteria

Ages
18 Years to o limit (—)
Sex
All

Inclusion Criteria

  • Study eligibility will include a confirmed diagnosis of Type 2 diabetes mellitus and a foot ulcer with an International Working Group of the Diabetic Foot (IWGDF) PEDIS classifications (as listed below) of at least 4 weeks duration.
  • 1\.Perfusion: Grades 1\-3
  • 2\.Depth: Grades 1\-3
  • 3\.Infection: Grades 1\-3
  • 4\.Sensation: Grades 1 and 2

Exclusion Criteria

  • Patients with a Grade 4 infection rating according to the IWGDF PEDIS classification system will be excluded as systemic signs will usually require hospital admission. Patients with phenylketonuria, sepsis, chronic renal failure, malignancy, and chronic inflammatory bowel disease, will be excluded for health and safety reasons. Individuals receiving hydroxyurea or greater than 10 mg prednisolone or 1\.5 mg dexamethasone per day will also be excluded as these drugs can impact on the rate of healing of diabetic foot ulcers. Individuals using insulin to manage their diabetes will also be excluded.

Investigators

Sponsor
orthern Hospital

Similar Trials